Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients.

NCT03279133 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to find eligible patients with untreated hepatitis C virus.

Conditions

Hematopoietic Stem Cell Transplantation

Interventions

DRUG: Ledipasvir 90mg/Sofosubvir 400mg

Sponsor

Kaiser Permanente

Collaborators

[object Object]